RT @ProbiodrugAG: SAPHIR data - Safety, tolerability and efficacy of the #glutaminylcyclase inhibitor #PQ912 - in peer reviewed journal Al…
Congratulations to @ProbiodrugAG on a successful proof-of-concept study for PQ912 in #Alzheimers, which saw promising exploratory efficacy findings, including cognition measured using the Cogstate NTB, indicating improving CNS function. https://t.co/OJ71yT
This publication summarizes and highlights the results of the SAPHIR trial made by #Probiodrug
RT @ProbiodrugAG: SAPHIR data - Safety, tolerability and efficacy of the #glutaminylcyclase inhibitor #PQ912 - in peer reviewed journal Al…
SAPHIR data - Safety, tolerability and efficacy of the #glutaminylcyclase inhibitor #PQ912 - in peer reviewed journal Alzheimer´s Research & Therapy (#BioMedCentral) published! Find link to publication here: https://t.co/zZUrNm1XkW https://t.co/RJbNN8